• Image of WELIREG medication Image of WELIREG medication
    • WELIREG

    • QTY 90
    • 40 MG
    • Tablet
    • Near  77381

BELZUTIFAN (bel ZUE ti fan) treats kidney cancer. It may also be used to treat some types of cancer and tumors in people with von Hippel-Lindau syndrome. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.


WELIREG Lifestyle Interactions

  • Belzutifan 40mg, Oral tablet

    Interaction: Grapefruit juice
    Severity: Major
    Notes for Consumers: Do not drink grapefruit juice or eat grapefruit while taking this medication. Grapefruit may alter the effects of your medication. Serious side effects may occur. Contact your care team right away if you experience new or worsening side effects.
    Notes for Professionals: Advise patients to avoid grapefruit and grapefruit juice during belzutifan treatment due to the risk for increased belzutifan exposure and adverse reactions. Belzutifan is a CYP2C19 substrate and grapefruit juice is a CYP2C19 inhibitor.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.